

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.93860898 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.76468146 |
| 3 | sodium ion export (GO:0071436) | 5.61130215 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.59818306 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.56955577 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 5.52948321 |
| 7 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.37906143 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.26882298 |
| 9 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.15122835 |
| 10 | protein localization to synapse (GO:0035418) | 5.14199912 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.13055829 |
| 12 | glutamate secretion (GO:0014047) | 5.09923598 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.09649891 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.96416491 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.82408809 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.78631251 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.62351275 |
| 18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.60733106 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.56524404 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.51546693 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.50898376 |
| 22 | presynaptic membrane organization (GO:0097090) | 4.46061232 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.38732291 |
| 24 | synaptic vesicle maturation (GO:0016188) | 4.38586351 |
| 25 | postsynaptic membrane organization (GO:0001941) | 4.36490805 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.35286013 |
| 27 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.35280752 |
| 28 | * neuron-neuron synaptic transmission (GO:0007270) | 4.34621114 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.33139805 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.32050434 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.28749442 |
| 32 | cellular sodium ion homeostasis (GO:0006883) | 4.16657966 |
| 33 | L-amino acid import (GO:0043092) | 4.15174934 |
| 34 | potassium ion homeostasis (GO:0055075) | 4.10089776 |
| 35 | exploration behavior (GO:0035640) | 4.06206952 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.96652712 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.95250582 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.93486179 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.91561892 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.90260375 |
| 41 | cerebellar granule cell differentiation (GO:0021707) | 3.84718097 |
| 42 | neuron recognition (GO:0008038) | 3.82377552 |
| 43 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.82321580 |
| 44 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.81277069 |
| 45 | amino acid import (GO:0043090) | 3.79019603 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.76501575 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.73398008 |
| 48 | potassium ion import (GO:0010107) | 3.72487888 |
| 49 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.71844606 |
| 50 | neurotransmitter transport (GO:0006836) | 3.69523387 |
| 51 | cell differentiation in hindbrain (GO:0021533) | 3.68454637 |
| 52 | cell communication by electrical coupling (GO:0010644) | 3.68446044 |
| 53 | neuronal ion channel clustering (GO:0045161) | 3.66895905 |
| 54 | positive regulation of membrane potential (GO:0045838) | 3.66411417 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.65687346 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.65451480 |
| 57 | cerebellar Purkinje cell layer development (GO:0021680) | 3.61527218 |
| 58 | long-term memory (GO:0007616) | 3.60778419 |
| 59 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.58314449 |
| 60 | regulation of synapse maturation (GO:0090128) | 3.57371255 |
| 61 | positive regulation of synapse assembly (GO:0051965) | 3.57015959 |
| 62 | startle response (GO:0001964) | 3.55522511 |
| 63 | positive regulation of dendritic spine development (GO:0060999) | 3.53235588 |
| 64 | synaptic vesicle endocytosis (GO:0048488) | 3.51576880 |
| 65 | detection of calcium ion (GO:0005513) | 3.48733452 |
| 66 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48168441 |
| 67 | regulation of glutamate secretion (GO:0014048) | 3.47744572 |
| 68 | regulation of neurotransmitter secretion (GO:0046928) | 3.47716998 |
| 69 | proline transport (GO:0015824) | 3.45379717 |
| 70 | acidic amino acid transport (GO:0015800) | 3.43401956 |
| 71 | C4-dicarboxylate transport (GO:0015740) | 3.43004730 |
| 72 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.40516397 |
| 73 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.40516397 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 3.39319978 |
| 75 | neurofilament cytoskeleton organization (GO:0060052) | 3.38731159 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 3.37745187 |
| 77 | behavioral fear response (GO:0001662) | 3.37062344 |
| 78 | behavioral defense response (GO:0002209) | 3.37062344 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.35956932 |
| 80 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.34203527 |
| 81 | central nervous system myelination (GO:0022010) | 3.33774478 |
| 82 | axon ensheathment in central nervous system (GO:0032291) | 3.33774478 |
| 83 | neurotransmitter uptake (GO:0001504) | 3.33308526 |
| 84 | behavioral response to cocaine (GO:0048148) | 3.32452348 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 3.29562378 |
| 86 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29382734 |
| 87 | regulation of synapse structural plasticity (GO:0051823) | 3.28720956 |
| 88 | axonal fasciculation (GO:0007413) | 3.27831328 |
| 89 | transferrin transport (GO:0033572) | 3.26650418 |
| 90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.24837119 |
| 91 | mechanosensory behavior (GO:0007638) | 3.23773189 |
| 92 | layer formation in cerebral cortex (GO:0021819) | 3.23247596 |
| 93 | synapse assembly (GO:0007416) | 3.23066115 |
| 94 | membrane depolarization (GO:0051899) | 3.21793113 |
| 95 | fear response (GO:0042596) | 3.21614620 |
| 96 | adult walking behavior (GO:0007628) | 3.20886063 |
| 97 | regulation of female receptivity (GO:0045924) | 3.20484669 |
| 98 | short-term memory (GO:0007614) | 3.19221783 |
| 99 | regulation of dendritic spine development (GO:0060998) | 3.18504926 |
| 100 | serotonin metabolic process (GO:0042428) | 3.18223315 |
| 101 | positive regulation of synaptic transmission (GO:0050806) | 3.18026677 |
| 102 | cellular potassium ion homeostasis (GO:0030007) | 3.18014465 |
| 103 | female mating behavior (GO:0060180) | 3.17764430 |
| 104 | synaptic vesicle transport (GO:0048489) | 3.17731098 |
| 105 | establishment of synaptic vesicle localization (GO:0097480) | 3.17731098 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17669978 |
| 107 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.17537141 |
| 108 | regulation of neurotransmitter transport (GO:0051588) | 3.16574636 |
| 109 | neuromuscular synaptic transmission (GO:0007274) | 3.16117168 |
| 110 | neuromuscular process controlling posture (GO:0050884) | 3.15649005 |
| 111 | * synaptic transmission (GO:0007268) | 3.14251481 |
| 112 | auditory behavior (GO:0031223) | 3.13159023 |
| 113 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11093651 |
| 114 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10366035 |
| 115 | membrane hyperpolarization (GO:0060081) | 3.09648038 |
| 116 | learning (GO:0007612) | 3.09483545 |
| 117 | regulation of vesicle fusion (GO:0031338) | 3.07612039 |
| 118 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06550644 |
| 119 | activation of protein kinase A activity (GO:0034199) | 3.06261432 |
| 120 | dendritic spine morphogenesis (GO:0060997) | 3.05692243 |
| 121 | ferric iron transport (GO:0015682) | 3.04388409 |
| 122 | trivalent inorganic cation transport (GO:0072512) | 3.04388409 |
| 123 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.03902650 |
| 124 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.03545107 |
| 125 | regulation of synaptic transmission (GO:0050804) | 3.03439767 |
| 126 | membrane depolarization during action potential (GO:0086010) | 3.01907200 |
| 127 | * response to histamine (GO:0034776) | 3.01642837 |
| 128 | regulation of synapse assembly (GO:0051963) | 2.99427767 |
| 129 | striatum development (GO:0021756) | 2.95654297 |
| 130 | response to auditory stimulus (GO:0010996) | 2.94437409 |
| 131 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91932095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.94783308 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.48203903 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11636290 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02300034 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99233505 |
| 6 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.72518361 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65636286 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60555864 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50864835 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50399862 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50399862 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50137028 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.49925948 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49124740 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37917121 |
| 16 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.36038029 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35499848 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30541362 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29265241 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23421797 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.20949555 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18425710 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18233363 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.09670579 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07327367 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05627619 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04290837 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02511644 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99706762 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93189151 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.91736727 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.84160730 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83682532 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81554530 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80705878 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80028735 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78778849 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72063841 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72056557 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66068821 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64672901 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61947627 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.61805191 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55466677 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53604868 |
| 46 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49835269 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48020400 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47574287 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47463284 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46798186 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46674236 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44392326 |
| 53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44118675 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43891008 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41455434 |
| 56 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38803592 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36061316 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32898919 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32295265 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30760210 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29835269 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28098749 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27764110 |
| 64 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25453077 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21726401 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20253235 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19022475 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16662861 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16373467 |
| 70 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16219691 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15273789 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13703227 |
| 73 | JUN_21703547_ChIP-Seq_K562_Human | 1.13211882 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11528601 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10474671 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10060334 |
| 77 | AR_19668381_ChIP-Seq_PC3_Human | 1.09924399 |
| 78 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08378698 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07751879 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07733995 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07337022 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06974183 |
| 83 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02514327 |
| 84 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01994113 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01559234 |
| 86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00729848 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00469627 |
| 88 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00417487 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97619827 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97619827 |
| 91 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97587843 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97468707 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97255277 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96954719 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96933063 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96791932 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95953235 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94909642 |
| 99 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.94666634 |
| 100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93291725 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93177372 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92574368 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.90875824 |
| 104 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90643964 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90136301 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89897666 |
| 107 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89849722 |
| 108 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89642079 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89387572 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86824687 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85289447 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84830154 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83757727 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82185173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.52334771 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.36291251 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.02305903 |
| 4 | MP0009046_muscle_twitch | 3.56208371 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.54839448 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.33976022 |
| 7 | * MP0002064_seizures | 3.30235441 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.28159768 |
| 9 | MP0004270_analgesia | 3.23336113 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.94561864 |
| 11 | MP0002736_abnormal_nociception_after | 2.86940540 |
| 12 | * MP0002272_abnormal_nervous_system | 2.67563789 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.65142965 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.60641679 |
| 15 | MP0001486_abnormal_startle_reflex | 2.52109659 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.46844125 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.36613086 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.34715019 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.27789037 |
| 20 | MP0002822_catalepsy | 2.25837185 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.20934321 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.94120092 |
| 23 | MP0001970_abnormal_pain_threshold | 1.94077901 |
| 24 | MP0002184_abnormal_innervation | 1.93830790 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.92959690 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.90815836 |
| 27 | MP0001984_abnormal_olfaction | 1.87124331 |
| 28 | MP0003787_abnormal_imprinting | 1.85678236 |
| 29 | MP0003879_abnormal_hair_cell | 1.82071379 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.79694083 |
| 31 | MP0001529_abnormal_vocalization | 1.78578124 |
| 32 | MP0004924_abnormal_behavior | 1.75852652 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.75852652 |
| 34 | MP0001188_hyperpigmentation | 1.74982859 |
| 35 | MP0000778_abnormal_nervous_system | 1.70836179 |
| 36 | MP0008569_lethality_at_weaning | 1.69273437 |
| 37 | MP0003122_maternal_imprinting | 1.65175265 |
| 38 | MP0003329_amyloid_beta_deposits | 1.56781486 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.53877952 |
| 40 | MP0004142_abnormal_muscle_tone | 1.50839683 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.46588236 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.42778270 |
| 43 | * MP0002066_abnormal_motor_capabilities/c | 1.39405440 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.39178983 |
| 45 | MP0001905_abnormal_dopamine_level | 1.37442324 |
| 46 | MP0000955_abnormal_spinal_cord | 1.36846460 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.35750616 |
| 48 | * MP0002882_abnormal_neuron_morphology | 1.34385067 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.32478436 |
| 50 | MP0003690_abnormal_glial_cell | 1.30596715 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.30003308 |
| 52 | MP0000920_abnormal_myelination | 1.29525882 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.26237920 |
| 54 | MP0003123_paternal_imprinting | 1.18577428 |
| 55 | MP0003633_abnormal_nervous_system | 1.12787382 |
| 56 | MP0004858_abnormal_nervous_system | 1.12700374 |
| 57 | MP0004147_increased_porphyrin_level | 1.11909587 |
| 58 | MP0000751_myopathy | 1.09667946 |
| 59 | MP0004742_abnormal_vestibular_system | 1.04420558 |
| 60 | MP0002152_abnormal_brain_morphology | 1.03312850 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.02927056 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.00933951 |
| 63 | MP0003631_nervous_system_phenotype | 1.00441241 |
| 64 | MP0002229_neurodegeneration | 0.97879826 |
| 65 | MP0001963_abnormal_hearing_physiology | 0.97467485 |
| 66 | MP0008872_abnormal_physiological_respon | 0.96691615 |
| 67 | MP0004215_abnormal_myocardial_fiber | 0.94098153 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 0.92793521 |
| 69 | MP0004085_abnormal_heartbeat | 0.91642905 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.91385034 |
| 71 | MP0004885_abnormal_endolymph | 0.90617573 |
| 72 | MP0005499_abnormal_olfactory_system | 0.87892498 |
| 73 | MP0005394_taste/olfaction_phenotype | 0.87892498 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.85025247 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.83014167 |
| 76 | MP0002752_abnormal_somatic_nervous | 0.82384444 |
| 77 | MP0004484_altered_response_of | 0.79828316 |
| 78 | MP0005171_absent_coat_pigmentation | 0.79267590 |
| 79 | MP0001664_abnormal_digestion | 0.76695246 |
| 80 | MP0005535_abnormal_body_temperature | 0.74943426 |
| 81 | MP0004233_abnormal_muscle_weight | 0.74295204 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.73524906 |
| 83 | MP0008877_abnormal_DNA_methylation | 0.71649356 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.70996832 |
| 85 | MP0003632_abnormal_nervous_system | 0.70273337 |
| 86 | * MP0008874_decreased_physiological_sensi | 0.69569191 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.66575033 |
| 88 | MP0003121_genomic_imprinting | 0.66046026 |
| 89 | MP0000026_abnormal_inner_ear | 0.65831514 |
| 90 | MP0003646_muscle_fatigue | 0.65374647 |
| 91 | MP0001177_atelectasis | 0.64892352 |
| 92 | MP0000604_amyloidosis | 0.64782721 |
| 93 | MP0003634_abnormal_glial_cell | 0.62488552 |
| 94 | MP0002090_abnormal_vision | 0.61396378 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.60309427 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.60073694 |
| 97 | MP0001943_abnormal_respiration | 0.59906528 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.57845504 |
| 99 | * MP0010768_mortality/aging | 0.54276318 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.53522035 |
| 101 | * MP0010770_preweaning_lethality | 0.53492206 |
| 102 | * MP0002082_postnatal_lethality | 0.53492206 |
| 103 | MP0005187_abnormal_penis_morphology | 0.53389142 |
| 104 | MP0000566_synostosis | 0.53248778 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.53117099 |
| 106 | MP0004043_abnormal_pH_regulation | 0.52895664 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.52870447 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.52511116 |
| 109 | MP0005409_darkened_coat_color | 0.51716021 |
| 110 | * MP0010769_abnormal_survival | 0.51061676 |
| 111 | MP0003861_abnormal_nervous_system | 0.49811116 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.49498326 |
| 113 | MP0003956_abnormal_body_size | 0.48929322 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.47411883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.14370597 |
| 2 | Epileptic encephalopathy (HP:0200134) | 6.21339773 |
| 3 | * Focal seizures (HP:0007359) | 5.39512145 |
| 4 | * Atonic seizures (HP:0010819) | 5.22968455 |
| 5 | Hyperventilation (HP:0002883) | 5.19240160 |
| 6 | Myokymia (HP:0002411) | 5.07785618 |
| 7 | * Febrile seizures (HP:0002373) | 4.92641157 |
| 8 | Visual hallucinations (HP:0002367) | 4.62792793 |
| 9 | * Absence seizures (HP:0002121) | 4.48264663 |
| 10 | * Dialeptic seizures (HP:0011146) | 4.18193500 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.15887116 |
| 12 | Broad-based gait (HP:0002136) | 3.87557204 |
| 13 | Intention tremor (HP:0002080) | 3.71356468 |
| 14 | * Generalized tonic-clonic seizures (HP:0002069) | 3.67515938 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.52398474 |
| 16 | Poor eye contact (HP:0000817) | 3.14607560 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.13501553 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.13501553 |
| 19 | Truncal ataxia (HP:0002078) | 3.11781909 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.11199792 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.10977416 |
| 22 | Abnormal eating behavior (HP:0100738) | 3.10100180 |
| 23 | Progressive inability to walk (HP:0002505) | 3.09854328 |
| 24 | Amblyopia (HP:0000646) | 3.08398629 |
| 25 | Excessive salivation (HP:0003781) | 3.01734853 |
| 26 | Drooling (HP:0002307) | 3.01734853 |
| 27 | Abnormal social behavior (HP:0012433) | 2.91921670 |
| 28 | Impaired social interactions (HP:0000735) | 2.91921670 |
| 29 | Polyphagia (HP:0002591) | 2.91803671 |
| 30 | Cerebral hypomyelination (HP:0006808) | 2.88929301 |
| 31 | Abnormal hair whorl (HP:0010721) | 2.87118213 |
| 32 | Epileptiform EEG discharges (HP:0011182) | 2.85428627 |
| 33 | Inability to walk (HP:0002540) | 2.82928821 |
| 34 | Gait imbalance (HP:0002141) | 2.80626156 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.80322645 |
| 36 | Akinesia (HP:0002304) | 2.78411441 |
| 37 | Pheochromocytoma (HP:0002666) | 2.77798571 |
| 38 | Protruding tongue (HP:0010808) | 2.71164610 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.70908846 |
| 40 | Diplopia (HP:0000651) | 2.70908846 |
| 41 | Dysmetric saccades (HP:0000641) | 2.70861419 |
| 42 | Action tremor (HP:0002345) | 2.69090805 |
| 43 | Papilledema (HP:0001085) | 2.67561906 |
| 44 | Anxiety (HP:0000739) | 2.65121086 |
| 45 | Lower limb muscle weakness (HP:0007340) | 2.62551919 |
| 46 | Depression (HP:0000716) | 2.59687006 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.58942584 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.54075687 |
| 49 | Dysmetria (HP:0001310) | 2.51980127 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.50318009 |
| 51 | Scanning speech (HP:0002168) | 2.50276267 |
| 52 | Absent speech (HP:0001344) | 2.49642137 |
| 53 | Congenital primary aphakia (HP:0007707) | 2.46988976 |
| 54 | Medial flaring of the eyebrow (HP:0010747) | 2.46947517 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.45583195 |
| 56 | Status epilepticus (HP:0002133) | 2.45116128 |
| 57 | Impaired smooth pursuit (HP:0007772) | 2.44487040 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43736837 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.43184924 |
| 60 | Annular pancreas (HP:0001734) | 2.41613727 |
| 61 | Abnormality of saccadic eye movements (HP:0000570) | 2.40592648 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.40258071 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39999496 |
| 64 | Hemiparesis (HP:0001269) | 2.36645159 |
| 65 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.34932196 |
| 66 | Nephrogenic diabetes insipidus (HP:0009806) | 2.34308653 |
| 67 | Termporal pattern (HP:0011008) | 2.34072632 |
| 68 | Insidious onset (HP:0003587) | 2.34072632 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.32117762 |
| 70 | Poor suck (HP:0002033) | 2.31518468 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.31433568 |
| 72 | Tetraplegia (HP:0002445) | 2.30948006 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.30741152 |
| 74 | Postural tremor (HP:0002174) | 2.30634056 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.26638905 |
| 76 | Ankle clonus (HP:0011448) | 2.25833121 |
| 77 | Limb dystonia (HP:0002451) | 2.25783914 |
| 78 | Sleep apnea (HP:0010535) | 2.24967822 |
| 79 | Genetic anticipation (HP:0003743) | 2.22441703 |
| 80 | Mutism (HP:0002300) | 2.22390396 |
| 81 | Peripheral hypomyelination (HP:0007182) | 2.22310031 |
| 82 | Bradykinesia (HP:0002067) | 2.21497934 |
| 83 | Blue irides (HP:0000635) | 2.21271290 |
| 84 | Failure to thrive in infancy (HP:0001531) | 2.18135022 |
| 85 | Postural instability (HP:0002172) | 2.15429264 |
| 86 | Hyperthyroidism (HP:0000836) | 2.15405975 |
| 87 | Clonus (HP:0002169) | 2.14239028 |
| 88 | Specific learning disability (HP:0001328) | 2.13382912 |
| 89 | Urinary urgency (HP:0000012) | 2.13114506 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.12399817 |
| 91 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12192533 |
| 92 | Generalized myoclonic seizures (HP:0002123) | 2.10562893 |
| 93 | CNS hypomyelination (HP:0003429) | 2.08725049 |
| 94 | Horizontal nystagmus (HP:0000666) | 2.07155404 |
| 95 | Abnormality of the corticospinal tract (HP:0002492) | 2.05351984 |
| 96 | Rigidity (HP:0002063) | 2.03742124 |
| 97 | Stereotypic behavior (HP:0000733) | 2.02179200 |
| 98 | Abnormality of salivation (HP:0100755) | 2.02160751 |
| 99 | Narrow nasal bridge (HP:0000446) | 2.00974440 |
| 100 | Impaired vibratory sensation (HP:0002495) | 2.00270542 |
| 101 | Spastic gait (HP:0002064) | 1.99988615 |
| 102 | Amyotrophic lateral sclerosis (HP:0007354) | 1.99705529 |
| 103 | Esotropia (HP:0000565) | 1.95701180 |
| 104 | Limb ataxia (HP:0002070) | 1.93778847 |
| 105 | Resting tremor (HP:0002322) | 1.93263965 |
| 106 | Apathy (HP:0000741) | 1.92334557 |
| 107 | Spastic tetraplegia (HP:0002510) | 1.92129446 |
| 108 | Spastic tetraparesis (HP:0001285) | 1.90259191 |
| 109 | Abnormality of the labia minora (HP:0012880) | 1.90117375 |
| 110 | Gait ataxia (HP:0002066) | 1.90011983 |
| 111 | Hemiplegia (HP:0002301) | 1.89845523 |
| 112 | Incomplete penetrance (HP:0003829) | 1.89726322 |
| 113 | Torticollis (HP:0000473) | 1.87642578 |
| 114 | Genital tract atresia (HP:0001827) | 1.86246713 |
| 115 | Choreoathetosis (HP:0001266) | 1.86229380 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.85970034 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.85041995 |
| 118 | Oligomenorrhea (HP:0000876) | 1.85031224 |
| 119 | Psychosis (HP:0000709) | 1.84864861 |
| 120 | Memory impairment (HP:0002354) | 1.83132624 |
| 121 | Vaginal atresia (HP:0000148) | 1.82935037 |
| 122 | Thickened helices (HP:0000391) | 1.81948075 |
| 123 | Absent/shortened dynein arms (HP:0200106) | 1.81925531 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.81925531 |
| 125 | Hypoventilation (HP:0002791) | 1.81554601 |
| 126 | Delusions (HP:0000746) | 1.81086537 |
| 127 | Focal dystonia (HP:0004373) | 1.80163567 |
| 128 | Ventricular fibrillation (HP:0001663) | 1.79740859 |
| 129 | Poor coordination (HP:0002370) | 1.79513829 |
| 130 | Sensory axonal neuropathy (HP:0003390) | 1.76644453 |
| 131 | Dysarthria (HP:0001260) | 1.75756216 |
| 132 | Rapidly progressive (HP:0003678) | 1.74182675 |
| 133 | Diminished motivation (HP:0000745) | 1.72980631 |
| 134 | Agnosia (HP:0010524) | 1.71426137 |
| 135 | Increased circulating renin level (HP:0000848) | 1.70596698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.56089618 |
| 2 | NTRK3 | 4.06035253 |
| 3 | EPHA4 | 3.77428811 |
| 4 | MAP3K4 | 3.39154578 |
| 5 | MAP2K7 | 3.30141510 |
| 6 | MAP3K12 | 2.91552007 |
| 7 | MARK1 | 2.69780338 |
| 8 | MAP3K9 | 2.57614685 |
| 9 | DAPK2 | 2.47180289 |
| 10 | CDK19 | 2.24212401 |
| 11 | MINK1 | 2.22672601 |
| 12 | PLK2 | 2.11930950 |
| 13 | MAP2K4 | 2.09966523 |
| 14 | NTRK2 | 1.90475536 |
| 15 | DAPK1 | 1.90380672 |
| 16 | AKT3 | 1.88968054 |
| 17 | RIPK4 | 1.77640381 |
| 18 | CCNB1 | 1.68566103 |
| 19 | PNCK | 1.66144605 |
| 20 | PRPF4B | 1.52622428 |
| 21 | GRK5 | 1.51533289 |
| 22 | PAK6 | 1.49374460 |
| 23 | MAPK13 | 1.43028667 |
| 24 | ARAF | 1.35013843 |
| 25 | OXSR1 | 1.34740010 |
| 26 | KSR1 | 1.32684430 |
| 27 | CDK5 | 1.28100194 |
| 28 | PRKCG | 1.27765026 |
| 29 | TNIK | 1.25833593 |
| 30 | NME1 | 1.23939026 |
| 31 | CAMKK2 | 1.23326969 |
| 32 | SIK2 | 1.10352361 |
| 33 | CAMKK1 | 1.07708225 |
| 34 | KSR2 | 1.06855069 |
| 35 | SIK3 | 1.05424026 |
| 36 | TSSK6 | 1.05372577 |
| 37 | FES | 1.05272078 |
| 38 | SGK2 | 1.03667976 |
| 39 | * CAMK2A | 1.02687260 |
| 40 | SGK223 | 1.01846123 |
| 41 | SGK494 | 1.01846123 |
| 42 | PDK3 | 0.96214391 |
| 43 | PDK4 | 0.96214391 |
| 44 | CAMK2B | 0.94317788 |
| 45 | BMPR2 | 0.92800707 |
| 46 | NTRK1 | 0.92074545 |
| 47 | PTK2B | 0.85456529 |
| 48 | BRAF | 0.84533288 |
| 49 | CDK18 | 0.82332277 |
| 50 | UHMK1 | 0.77985883 |
| 51 | CSNK1A1L | 0.77464968 |
| 52 | CDK15 | 0.76153645 |
| 53 | CDK14 | 0.75889528 |
| 54 | CSNK1G3 | 0.73725168 |
| 55 | DYRK1A | 0.71852939 |
| 56 | CAMK1 | 0.70386384 |
| 57 | PHKG2 | 0.69086713 |
| 58 | PHKG1 | 0.69086713 |
| 59 | STK38 | 0.67137174 |
| 60 | LIMK1 | 0.66837132 |
| 61 | WNK3 | 0.65059168 |
| 62 | WNK1 | 0.64773638 |
| 63 | CDK11A | 0.64399978 |
| 64 | RIPK1 | 0.63780203 |
| 65 | MARK2 | 0.63075895 |
| 66 | GRK7 | 0.62001419 |
| 67 | BCR | 0.61522652 |
| 68 | FGR | 0.61494814 |
| 69 | SGK3 | 0.61405284 |
| 70 | SGK1 | 0.61397548 |
| 71 | ALK | 0.60244971 |
| 72 | TNK2 | 0.58002913 |
| 73 | CAMK2D | 0.57707283 |
| 74 | MAP3K13 | 0.57332718 |
| 75 | MAPK10 | 0.57194234 |
| 76 | * PRKCE | 0.56988623 |
| 77 | PKN1 | 0.56528178 |
| 78 | STK11 | 0.55966865 |
| 79 | RAF1 | 0.54017283 |
| 80 | ADRBK2 | 0.53888947 |
| 81 | PRKG1 | 0.53803739 |
| 82 | MAP3K11 | 0.53049934 |
| 83 | NEK6 | 0.52920942 |
| 84 | FER | 0.52367577 |
| 85 | CAMK2G | 0.52054245 |
| 86 | MAP3K2 | 0.51544153 |
| 87 | CSNK1G1 | 0.51041814 |
| 88 | CSNK1G2 | 0.50912008 |
| 89 | FGFR2 | 0.50837395 |
| 90 | PRKD3 | 0.49626697 |
| 91 | PDK2 | 0.49425045 |
| 92 | TESK1 | 0.47440337 |
| 93 | MAP3K6 | 0.47196365 |
| 94 | ADRBK1 | 0.46803169 |
| 95 | MAPK12 | 0.46482776 |
| 96 | DAPK3 | 0.46256961 |
| 97 | PAK3 | 0.44204856 |
| 98 | * PRKCA | 0.43418966 |
| 99 | CDK3 | 0.43169935 |
| 100 | MUSK | 0.42646779 |
| 101 | ERBB4 | 0.42364292 |
| 102 | ROCK2 | 0.41385000 |
| 103 | PRKCH | 0.41377355 |
| 104 | * FYN | 0.40926909 |
| 105 | CSNK1D | 0.40836949 |
| 106 | NEK1 | 0.40627267 |
| 107 | MAP2K1 | 0.38314403 |
| 108 | PRKACA | 0.37470747 |
| 109 | PINK1 | 0.36602526 |
| 110 | LATS2 | 0.36424471 |
| 111 | PRKCZ | 0.36252824 |
| 112 | CSNK1A1 | 0.35732107 |
| 113 | CSNK1E | 0.35160829 |
| 114 | TYRO3 | 0.34631135 |
| 115 | RET | 0.34170477 |
| 116 | * RPS6KA3 | 0.33917897 |
| 117 | CAMK4 | 0.33807750 |
| 118 | DYRK2 | 0.33784796 |
| 119 | PDK1 | 0.32883261 |
| 120 | * PRKCB | 0.32040400 |
| 121 | MYLK | 0.30966811 |
| 122 | PDPK1 | 0.30686764 |
| 123 | TRIM28 | 0.27631559 |
| 124 | MAPK8 | 0.26128981 |
| 125 | MAP3K1 | 0.25022217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nicotine addiction_Homo sapiens_hsa05033 | 4.51867586 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.93918080 |
| 3 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.99706534 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.90184114 |
| 5 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.86158883 |
| 6 | * Morphine addiction_Homo sapiens_hsa05032 | 2.63848127 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58333328 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57281602 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.49624269 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49546471 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33367095 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.20778033 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09399651 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.05333147 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89884079 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84598703 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.79553596 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75744835 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.75426903 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.72469208 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71239048 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.64249703 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59647176 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58012324 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56549536 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.53461808 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48783812 |
| 28 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.42502358 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40054989 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33176535 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31245421 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29787913 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25742939 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23363645 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23313394 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20297262 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.16606073 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.15834020 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14917289 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13923705 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08870782 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.04067044 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01683460 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00767964 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96919912 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96243661 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96189248 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93677468 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92022535 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88343309 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86760205 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85564442 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83469250 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80388111 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79556147 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77159132 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.76359116 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.74249489 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71131345 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69796511 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69314696 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65412753 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.64074443 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63940835 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63893346 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62196238 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61908539 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55894692 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.54582804 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52259830 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51958509 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.51748006 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49426106 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48688798 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46878626 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45929875 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45589795 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44970835 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43480015 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40335328 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.40201217 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39838641 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39760911 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.38588551 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38563210 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37926148 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35417479 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34914680 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34761554 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34403639 |
| 91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34292633 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33714565 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33068768 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30520867 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30374165 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.30239353 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29148278 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27023240 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26026631 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25257744 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.24795848 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24407627 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23930764 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23102995 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21707120 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21583556 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21381658 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21359677 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20555242 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18429481 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17010994 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.15584451 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12893325 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.10587604 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10319322 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.09765682 |

